These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10560985)

  • 1. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.
    Chantilis SJ; Zeitoun KM; Patel SI; Johns DA; Madziar VA; McIntire DD
    Fertil Steril; 1999 Nov; 72(5):823-9. PubMed ID: 10560985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer.
    Damario MA; Goudas VT; Session DR; Hammitt DG; Dumesic DA
    Fertil Steril; 1999 Nov; 72(5):830-6. PubMed ID: 10560986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles.
    Propst AM; Hill JA; Ginsburg ES; Hurwitz S; Politch J; Yanushpolsky EH
    Fertil Steril; 2001 Dec; 76(6):1144-9. PubMed ID: 11730742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J;
    Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.
    Mitwally MF; Diamond MP; Abuzeid M
    Fertil Steril; 2010 Feb; 93(2):554-69. PubMed ID: 19362305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial.
    Silverberg KM; Vaughn TC; Hansard LJ; Burger NZ; Minter T
    Fertil Steril; 2012 Feb; 97(2):344-8. PubMed ID: 22188983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles.
    Jobanputra K; Toner JP; Denoncourt R; Gibbons WE
    Fertil Steril; 1999 Dec; 72(6):980-4. PubMed ID: 10593367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study.
    Lockwood G; Griesinger G; Cometti B;
    Fertil Steril; 2014 Jan; 101(1):112-119.e3. PubMed ID: 24140033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers.
    Wang LJ; Huang FJ; Kung FT; Lin PY; Chang SY; Lan KC
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):375-9. PubMed ID: 20045758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
    Simunic V; Tomic V; Tomic J; Nizic D
    Fertil Steril; 2007 Jan; 87(1):83-7. PubMed ID: 17081536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with progesterone gel for luteal support in a highly successful IVF programme.
    Schoolcraft WB; Hesla JS; Gee MJ
    Hum Reprod; 2000 Jun; 15(6):1284-8. PubMed ID: 10831556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial.
    Saunders H; Khan C; D'Hooghe T; Magnúsdóttir TB; Klingmann I; Hrafnsdóttir S;
    Hum Reprod; 2020 Feb; 35(2):355-363. PubMed ID: 32074281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer.
    Kaser DJ; Ginsburg ES; Missmer SA; Correia KF; Racowsky C
    Fertil Steril; 2012 Dec; 98(6):1464-9. PubMed ID: 22959457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan® and Crinone® 8.
    Michnova L; Dostal J; Kudela M; Hamal P; Langova K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):86-91. PubMed ID: 28323291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with a novel vaginal progesterone preparation in a donor oocyte program.
    Gibbons WE; Toner JP; Hamacher P; Kolm P
    Fertil Steril; 1998 Jan; 69(1):96-101. PubMed ID: 9457941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization.
    Baker VL; Jones CA; Doody K; Foulk R; Yee B; Adamson GD; Cometti B; DeVane G; Hubert G; Trevisan S; Hoehler F; Jones C; Soules M
    Hum Reprod; 2014 Oct; 29(10):2212-20. PubMed ID: 25100106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone.
    Pouly JL; Bassil S; Frydman R; Hedon B; Nicollet B; Prada Y; Antoine JM; Zambrano R; Donnez J
    Hum Reprod; 1996 Oct; 11(10):2085-9. PubMed ID: 8943507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial.
    Yanushpolsky E; Hurwitz S; Greenberg L; Racowsky C; Hornstein MD
    Fertil Steril; 2008 Feb; 89(2):485-7. PubMed ID: 17572412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal delivery of progesterone in donor oocyte therapy.
    Toner JP
    Hum Reprod; 2000 Jun; 15 Suppl 1():166-71. PubMed ID: 10928428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.